Botox .Not just for Beauty Coding Chemodenervation Presente - PowerPoint PPT Presentation

1 / 17
About This Presentation
Title:

Botox .Not just for Beauty Coding Chemodenervation Presente

Description:

Botox .Not just for Beauty Coding Chemodenervation Presented by Marisa Clauson, CPC CPT/HCPC Codes Applicable Modifiers Bundling Edits Local Carrier Determination ... – PowerPoint PPT presentation

Number of Views:83
Avg rating:3.0/5.0
Slides: 18
Provided by: silverdale8
Category:

less

Transcript and Presenter's Notes

Title: Botox .Not just for Beauty Coding Chemodenervation Presente


1
Botox.Not just for Beauty
  • Coding Chemodenervation
  • Presented by Marisa Clauson, CPC

2
Agenda
  • CPT/HCPC Codes
  • Applicable Modifiers
  • Bundling Edits
  • Local Carrier Determination (LCD)
  • Policies

3
CPT Codes
  • 64612 - Chemodenervation of muscle(s) muscle(s)
    innervated by facial nerve
  • 64613 - Chemodenervation of muscle(s) cervical
    spinal muscle(s)
  • 64614 - Chemodenervation of muscle(s)
    extremity(s) and/or trunk muscle(s)
  • This code describes injections into the patients
    face.
  • This code describes injection into muscles in the
    patients neck affecting the cervical muscles
  • This code describes injection into the limbs or
    trunk.

4
Guidance
  • If EMG guidance is used
  • 95874 Needle electromyography for guidance
    in conjunction with chemodenervation (list in
    addition to primary code)
  • If E-Stim guidance is used
  • 95873 Electrical stimulation for guidance in
    conjunction with chemodenervation (list in
    addition to primary code)

5
Additional CPTs
  • Be aware that there are multiple others codes
    used for coding of chemodernavation based on the
    type of service being rendered (ie., 64650
    Chemodenervation of eccrine glands both axillae)

6
HCPC Codes
  • J0585 OnaBotulinum toxin type A, 1 unit
  • Botox Type A is supplied in single dose vials of
    100 units.
  • If less than 100 units is given to a patient and
    the remainder is not used for another patient it
    is important
  • to document the wastage and bill appropriately.
  • J0587 RimaBotulinum toxin type B, 5 units

7
Body Areas Defined
  • Body areas are defined by CMS
  • One eye (including all muscles surrounding the
    eye and both upper and lower lids)
  • One side of the neck
  • One side of the face
  • All muscles of one limb and the associated girdle
    muscles

8
(No Transcript)
9
Modifiers
  • Modifiers may include 50, 51, and 59
  • 50 bilateral procedure
  • 64612 is identified in the MPFS database as a
    code for which the allowance for procedures
    performed bilaterally will be 150 of allowance
    for the unilateral service.
  • For non-Medicare payers, bilateral procedures may
    be reported on 2 lines using the RT and LT
    modifiers and reporting 1 unit of service for
    each.
  • 51 multiple procedures

10
Modifiers, Cont.
  • 59 to indicate two distinct procedures/services
    on the same date of service.
  • If the provider performes botulinum toxin
    injection to both sides of the neck, this would
    be reported to contractors who allow billing of 1
    unit of service per body area as 64613 and
    64613-59. The -59 modifier denotes the separate
    body area.
  • Note The 2001 coding guidance published in the
    American Medical Association CPT Assistant
    newsletter, indicates that "codes 6461264614
    should be reported only one time per procedure
    even if multiple injections are performed in
    sites along a single muscle or if several muscles
    are injected." (CPT Assistant. April 200111(4)).

11
Modifiers, Cont.
  • Modifier JW Drug amount discarded/not
    administered to any patient.
  • Medicare Carriers Manual (MCM) Chapter 17,
    Section 40 talks about the use of the JW modifier
    but gives individual carriers discretion as to
    whether or not they will require this modifier.
  • Currently, NAS does not require use of Modifier
    JW - See Medicare B News Issue 265 October 13
    2010

12
Medicares LCD
  • LCD L24280 Botulinum Toxin Type A B, eff
    2/27/12
  • Coverage Requirements
  • Patient with migraines lasting more than 4 hours
    a day greater than 15 days per month.
  • Documentation that traditional methods have been
    tried and have not proven to be successful.
  • Individual consideration can be requested via
    redetermination.

13
Insurance Policies
  • United Health Care
  • Botulinum Toxins A and B Effective 1/1/2012
  • Documentation that will support medical necessity
    for treatment of migraine headaches
  • Headache lasting at least 15 days per month for
    at least 3 months
  • Occurring in pts who have had five attacks
    fulfilling criteria for migraine without aura.
  • Headache has at least two of the following
    Unilateral location, pulsating quality, moderate
    or severe pain intensity, aggravated by physical
    activity lasting at least 8 days per month AND
    the patient has nausea and vomiting or
    photophobia and phonophobia.
  • No medication overuse and not attributed to
    another causative disorder.
  • Note Pt must have had failed trials of
    preventative anti-migraine medications.

14
Policies, Cont.
  • Aetna Botulinum Toxin
  • (Effective 7/29/96, last reviewed 02/21/2012)
  • Policy states that medical necessity is supported
    if the following are documented
  • Chronic migraines in adults who have tried and
    failed at least three classes of migraine
    prophylaxis medications. Pt must have tried each
    drug for a minimum of 2 months.
  • Migraine must last more than 4 hours a day, more
    than 14 days a month.
  • If the documentation doesnt meet the above
    requirements, the treatment is considered
    experimental and investigational.

15
Policies, Cont.
  • Cigna Onabotulinumtoxin A (Botox A) Eff.
    9/15/2010
  • Migraine treatment is covered when there is
    failure, contraindication, or intolerance to 2 or
    more different migraine prophylaxis medications.
  • If the above is documented appropriately to
    support medical necessity, coverage includes 4
    treatments in a 12 month period (one treatment
    every 90 days).
  • If the failure or contraindications are not
    documented to meet the coverage criteria above
    AND clinical improvement with previous Botox
    injections is documented but duration of benefit
    is less than 90 days then up to six treatments in
    a 12 mo period may be considered on an individual
    pt basis.

16
References
  • UHC Policy
  • https//www.unitedhealthcareonline.com/b2c/CmaActi
    on.do?channelId016228193392b010VgnVCM100000c52072
    0a____
  • UHC Specialty pharmacy enrollment request form
  • https//www.unitedhealthcareonline.com/b2c/CmaActi
    on.do?channelIdba7063a25103f010VgnVCM100000c52072
    0a____
  • Aetna Policy - http//www.aetna.com/cpb/medical/da
    ta/100_199/0113.html
  • Cigna Policy - http//www.cigna.com/assets/docs/he
    alth-care-professionals/coverage_positions/ph_5018
    _coveragepositioncriteria_botox.pdf
  • Noridians LCD www.noridianmedicare.com

17
Well, its not Botox, but it might just work!
Write a Comment
User Comments (0)
About PowerShow.com